Journal of Neurogastroenterology and Motility

The Korean Society of Neurogastroenterology and Motility (대한소화기 기능성질환 운동학회)
권호 표지
DOI QR코드

DOI QR Code

Overlap of Erosive and Non-erosive Reflux Diseases With Functional Gastrointestinal Disorders According to Rome III Criteria

  • Noh, Young-Wook (Department of Internal Medicine, Ewha Medical Research Institute, Ewha Womans University School of Medicine) ;
  • Jung, Hye-Kyung (Department of Internal Medicine, Ewha Medical Research Institute, Ewha Womans University School of Medicine) ;
  • Kim, Seong-Eun (Department of Internal Medicine, Ewha Medical Research Institute, Ewha Womans University School of Medicine) ;
  • Jung, Sung-Ae (Department of Internal Medicine, Ewha Medical Research Institute, Ewha Womans University School of Medicine)
  • Published : 2010.03.30
⟨ Previous Next ⟩

Abstract

Background/Aims : Gastroesophageal reflux disease (GERD) is increasing in Asian countries. Functional dyspepsia (FD) or irritable bowel syndrome (IBS) are also prevalent and commonly overlapped with GERD. This study was conducted to compare the proportion and risk factors for overlapping reflux esophagitis (RE) and non-erosive reflux disease (NERD) with functional gastrointestinal disorders (FGIDs). Methods : A total of 2,388 [male, 55.9%; mean age (${\pm}$ SD), 43.2 years (${\pm}$ 8.4)] Korean subjects who underwent the upper endoscopy for health screening were prospectively included. The subjects were asked about demographic, medical and social history by using a structured questionnaire, and FD and IBS were assessed according to the Rome III criteria. Results : The subjects with RE were 286 (12.0%, male 88.5%, 42.8 years) and 74 subjects had NERD (3.1%) while the prevalence of FD and IBS were 8.1% and 10.1%, respectively. The proportion of FD and IBS in NERD was higher than that of RE (74.3% vs. 10.5%, p = 0.000; 41.9% vs. 11.2%, p = 0.000, respectively). The epigastric pain syndrome (EPS) was more prevalent than postprandial distress syndrome in NERD. According to multiple regression analysis, high somatization score and the presence of FD increased the odd ratio for NERD. However, male gender and current smoker were significant risk factors for RE. Conclusions : Compared to RE, NERD is more frequently overlapped with FD, especially EPS, and also are associated with significantly increased frequency of IBS. Our data draws attention to the possibility of subgrouping FGIDs and GERD to be important in understanding the pathophysiology of these conditions.

Keywords

References

  1. Dent J, Brun J, Fendrick A, et al. An evidence-based appraisal of reflux disease management - the Genval Workshop Report. Gut 1999;44(suppl 2):S1-S16.
  2. Locke GR 3rd, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ 3rd. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 1997;112:1448-1456. https://doi.org/10.1016/S0016-5085(97)70025-8
  3. Agreus L, Svardsudd K, Talley NJ, Jones MP, Tibblin G. Natural history of gastroesophageal reflux disease and functional abdominal disorders: a population-based study. Am J Gastroenterol 2001;96:2905-2914.
  4. Fock KM, Talley NJ, Fass R, et al. Asia-Pacific consensus on the management of gastroesophageal reflux disease: update. J Gastroenterol Hepatol 2008;23:8-22.
  5. Dent J. Gastro-oesophageal reflux disease. Digestion 1998;59:433-445. https://doi.org/10.1159/000007521
  6. Lee SY, Lee KJ, Kim SJ, Cho SW. Prevalence and risk factors for overlaps between gastroesophageal reflux disease, dyspepsia, and irritable bowel syndrome: a population-based study. Digestion 2009;79:196-201. https://doi.org/10.1159/000211715
  7. Locke GR 3rd, Zinsmeister AR, Fett SL, Melton LJ 3rd, Talley NJ. Overlap of gastrointestinal symptom complexes in a US community. Neurogastroenterol Motil 2005;17:29-34. https://doi.org/10.1111/j.1365-2982.2004.00581.x
  8. Jung HK, Halder S, McNally M, et al. Overlap of gastro-oesophageal reflux disease and irritable bowel syndrome: prevalence and risk factors in the general population. Aliment Pharmacol Ther 2007;26:453-461. https://doi.org/10.1111/j.1365-2036.2007.03366.x
  9. Talley NJ, Ruff K, Jiang X, Jung HK. The Rome III Classification of dyspepsia: will it help research? Dig Dis 2008;26:203-209. https://doi.org/10.1159/000121347
  10. Talley NJ. Overlapping abdominal symptoms: why do GERD and IBS often coexist? Drugs Today 2006;42(suppl B):3-8.
  11. Pimentel M, Rossi F, Chow EJ, et al. Increased prevalence of irritable bowel syndrome in patients with gastroesophageal reflux. J Clin Gastroenterol 2002;34:221-224. https://doi.org/10.1097/00004836-200203000-00004
  12. Karamanolis G, Caenepeel P, Arts J, Tack J. Association of the predominant symptom with clinical characteristics and pathophysiological mechanisms in functional dyspepsia. Gastroenterology 2006;130:296-303. https://doi.org/10.1053/j.gastro.2005.10.019
  13. Tack J, Caenepeel P, Arts J, Lee KJ, Sifrim D, Janssens J. Prevalence of acid reflux in functional dyspepsia and its association with symptom profile. Gut 2005;54:1370-1376. https://doi.org/10.1136/gut.2004.053355
  14. Tack J, Talley NJ, Camilleri M, et al. Functional gastroduodenal disorders. Gastroenterology 2006;130:1466-1479. https://doi.org/10.1053/j.gastro.2005.11.059
  15. Aro P, Talley NJ, Ronkainen J, et al. Anxiety is associated with uninvestigated and functional dyspepsia (Rome III criteria) in a Swedish population-based study. Gastroenterology 2009;137:94-100. https://doi.org/10.1053/j.gastro.2009.03.039
  16. Talley NJ, Phillips SF, Melton LJ 3rd, Wiltgen C, Zinsmeister AR. A patient questionnaire to identify bowel disease. Ann Intern Med 1989;111:671-674. https://doi.org/10.7326/0003-4819-111-8-671
  17. Talley NJ, Phillips SF, Wiltgen CM, Zinsmeister AR, Melton LJ 3rd. Assessment of functional gastrointestinal disease: the bowel disease questionnaire. Mayo Clin Proc 1990;65:1456-1479. https://doi.org/10.1016/S0025-6196(12)62169-7
  18. Guillemin F, Saraux A, Fardellone P, Guggenbuhl P, Behier JM, Coste J. Detection of cases of inflammatory rheumatic disorders: performance of a telephone questionnaire designed for use by patient interviewers. Ann Rheum Dis 2003;62:957-963. https://doi.org/10.1136/ard.62.10.957
  19. Attanasio V, Andrasik F, Blanchard EB, Arena JG. Psychometric properties of the SUNYA revision of the Psychosomatic Symptom Checklist. J Behav Med 1984;7:247-257. https://doi.org/10.1007/BF00845390
  20. Song HJ, Jung HK, Yeom HJ, et al. Reliability and validity of Korean Bowel Disease Questionnaire and prevalence of functional gastrointestinal disorders in Korea [abstract]. Gut 2009;58(suppl II):A112.
  21. Yim JH, Bae JM, Choi SS, et al. The validity of modified Korean translated BEPSI as instrument of stress measurement in outpatient clinic. J Korean Acad Fam Med 1996;17:42-49.
  22. Song CH, Chung KI, Song SW, Kim KS. The effects of L-theanine containing functional beverage on mental relaxation and fatigue perception. J Korean Acad Fam Med 2002;23;637-645.
  23. Chung KI, Song CH. Clinical usefulness of fatigue severity scale for patients with fatigue, and anxiety or depression. Korean J Psychosom Med 2001;9:164-173.
  24. Lundell LR, Dent J, Bennett JR, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999;45:172-180. https://doi.org/10.1136/gut.45.2.172
  25. Fass R, Fennerty MB, Vakil N. Nonerosive reflux disease-current concepts and dilemmas. Am J Gastroenterol 2001;96:303-314.
  26. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006;130:1480-1491. https://doi.org/10.1053/j.gastro.2005.11.061
  27. Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006;101:1900-1920. https://doi.org/10.1111/j.1572-0241.2006.00630.x
  28. Fass R. Erosive esophagitis and nonerosive reflux disease (NERD): comparision of epidemiologic, physiologic, and therapeutic characteristics. J Clin Gastroenterol. 2007;41:131-137. https://doi.org/10.1097/01.mcg.0000225631.07039.6d
  29. Kitacpioglu G, Mandiracioglu A, Caymaz Bor C, Bor S. Overlap of symptoms of dyspepsia and gastroesophageal reflux in the community. Tur J Gastroenterol 2007;18:14-19.
  30. Nastaskin I, Mehdikhani E, Conklin J, Park S, Pimentel M. Studying the overlap between IBS and GERD: a systematic review of the literature. Dig Dis Sci 2006;51:2113-2120. https://doi.org/10.1007/s10620-006-9306-y
  31. Ferreira KT, Hill BS. The effect of low external pH on properties of the paracellular pathway and junctional structure in frog skin. J Physiol 1982;332:59-67.
  32. Hopwood D, Milne G, Logan KR. Electron microscopic changes in human oesophageal epithelium in oesophagitis. J Pathol 1979;129:161-167. https://doi.org/10.1002/path.1711290402
  33. Trimble KC, Pryde A, Heading RC. Lowered oesophageal sensory thresholds in patients with symptomatic but not excess gastro-oesophageal reflux: evidence for a spectrum of visceral sensitivity in GORD. Gut 1995;37:7-12. https://doi.org/10.1136/gut.37.1.7
  34. Bouin M, Plourde V, Boivin M, et al. Rectal distention testing in patients with irritable bowel syndrome: sensitivity, specificity, and predictive values of pain sensory thresholds. Gastroenterology 2002;122:1771-1777. https://doi.org/10.1053/gast.2002.33601
  35. Coffin B, Azpiroz F, Guarner F, Malagelada JR. Selective gastric hypersensitivity and reflex hyporeactivity in functional dyspepsia. Gastroenterology 1994;107:1345-1351.
  36. Halder SL, Locke GR 3rd, Schleck CD, Zinsmeister AR, Melton LJ 3rd, Talley NJ. Natural history of functional gastrointestinal disorders: a 12-year longitudinal population-based study. Gastroenterology 2007;133:799-807. https://doi.org/10.1053/j.gastro.2007.06.010
  37. Pogromov AP, Diukova GM, Rykova SM, Bein AM. Psycho-autonomic aspects in patients with gastroesophageal reflux disease, and functional esophageal disorders. Klin Med 2005;83:41-44.
  38. Fass R, Fullerton S, Tung S, Mayer EA. Sleep disturbances in clinic patients with functional bowel disorders. Am J Gastroenterol 2000;95:1195-2000. https://doi.org/10.1111/j.1572-0241.2000.02009.x
  39. American Gastroenterology Association. American Gastroenterological Association medical position statement: irritable bowel syndrome. Gastroenterology 2002;123:2105-2107. https://doi.org/10.1053/gast.2002.37095b
  40. Jung HK, Choung RS, Talley NJ. Gastroesophageal reflux disease and sleep disorders: evidence for a causal link and therapeutic implications. J Neurogastroenterol Motil 2010;16:22-29. https://doi.org/10.5056/jnm.2010.16.1.22
  41. Camilleri M, Dubois D, Coulie B, et al. Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States: results of the US upper gastrointestinal study. Clin Gastroenterol Hepatol 2005;3:543-552. https://doi.org/10.1016/S1542-3565(05)00153-9
  42. Carlsson R, Dent J, Bolling-Sternevald E, et al. The usefulness of a structured questionnaire in the assessment of symptomatic gastro-esophageal reflux disease. Scand J Gastroenterol 1998;33:1023-1029. https://doi.org/10.1080/003655298750026697
  43. Dent J. Definitions of reflux disease and its separation from dyspepsia. Gut 2002;50(suppl 4):iv17-iv20.
  44. Kim N, Lee SW, Cho SI, et al. The prevalence of and risk factors for erosive oesophagitis and non-erosive reflux disease: a nationwide multicentre prospective study in Korea. Aliment Pharmacol Ther 2008;27:173-185.
  45. Quigley EM. Functional dyspepsia (FD) and non-erosive reflux disease (NERD): overlapping or discrete entities? Best Pract Res Clin Gastroenterol 2004;18:695-706. https://doi.org/10.1016/j.bpg.2004.04.004
  46. Kim JH, Hwang JK, Kim J, et al. Endoscopic findings around the gastroesophageal junction: an experience from a tertiary hospital in Korea. Korean J Intern Med 2008;23:127-133. https://doi.org/10.3904/kjim.2008.23.3.127

Cited by

  1. Diagnosis of Functional Dyspepsia: a Systematic Review vol.55, pp.5, 2010, https://doi.org/10.4166/kjg.2010.55.5.296
  2. Functional gastrointestinal disorders and overlap syndrome in Korea vol.26, pp.suppl.s3, 2010, https://doi.org/10.1111/j.1440-1746.2011.06644.x
  3. Insights Into Gastroesophageal Reflux Disease–Associated Dyspeptic Symptoms vol.9, pp.10, 2011, https://doi.org/10.1016/j.cgh.2011.05.015
  4. Les troubles fonctionnels intestinaux en consultation de gastroentérologie à l’hôpital universitaire de l’Amitié de Bangui vol.6, pp.2, 2012, https://doi.org/10.1007/s12157-012-0372-9
  5. IsHelicobacter pyloriEradication Effective in Managing Functional Dyspepsia? vol.59, pp.2, 2010, https://doi.org/10.4166/kjg.2012.59.2.200
  6. Reflux and sex: what drives testing, what drives treatment? vol.24, pp.3, 2012, https://doi.org/10.1097/meg.0b013e32834f6baa
  7. A Study on the Efficacy of Rebamipide for Patients with Proton Pump Inhibitor-Refractory Non-Erosive Reflux Disease vol.57, pp.6, 2010, https://doi.org/10.1007/s10620-012-2087-6
  8. Funktionelle Dyspepsie und funktionelle Ösophaguserkrankungen : Epidemiologie und Pathophysiologie vol.8, pp.5, 2010, https://doi.org/10.1007/s11377-013-0780-4
  9. Overlap of functional dyspepsia and GERD-diagnostic and treatment implications vol.10, pp.3, 2013, https://doi.org/10.1038/nrgastro.2012.253
  10. Functional dyspepsia-symptoms, definitions and validity of the Rome III criteria vol.10, pp.3, 2010, https://doi.org/10.1038/nrgastro.2013.14
  11. DA-9701: A New Multi-Acting Drug for the Treatment of Functional Dyspepsia vol.21, pp.3, 2013, https://doi.org/10.4062/biomolther.2012.096
  12. Efficacy and Safety of New Prokinetic Agent Benachio Q Solution® in Patients with Postprandial Distress Syndrome Subtype in Functional Dyspepsia: A Single-center, Randomized, Double-blind, Placebo vol.66, pp.1, 2010, https://doi.org/10.4166/kjg.2015.66.1.17
  13. Epidemiology of Functional Gastrointestinal Disorders in Japan and in the World vol.21, pp.3, 2010, https://doi.org/10.5056/jnm14165
  14. Reduction in duodenal endocrine cells in irritable bowel syndrome is associated with stem cell abnormalities vol.21, pp.32, 2010, https://doi.org/10.3748/wjg.v21.i32.9577
  15. Epidemiology of Uninvestigated Dyspepsia and Functional Dyspepsia in Asia vol.16, pp.4, 2010, https://doi.org/10.14442/jgfm.16.4_235
  16. Increase in plasma acyl ghrelin levels is associated with abatement of dyspepsia following Helicobacter pylori eradication vol.51, pp.6, 2010, https://doi.org/10.1007/s00535-015-1124-6
  17. Irritable bowel syndrome subtypes: Clinical and psychological features, body mass index and comorbidities vol.108, pp.2, 2010, https://doi.org/10.17235/reed.2015.3979/2015
  18. Effective and safe proton pump inhibitor therapy in acid-related diseases – A position paper addressing benefits and potential harms of acid suppression vol.14, pp.1, 2010, https://doi.org/10.1186/s12916-016-0718-z
  19. Possibilities of pH impedance and high-resolution manometry in managing patients with refractory gastroesophageal reflux disease vol.89, pp.2, 2017, https://doi.org/10.17116/terarkh201789276-83
  20. Overlap between irritable bowel syndrome and functional dyspepsia including subtype analyses vol.32, pp.9, 2010, https://doi.org/10.1111/jgh.13756
  21. Prevalence and Risk Factors of Functional Dyspepsia in Health Check-up Population: A Nationwide Multicenter Prospective Study vol.24, pp.4, 2010, https://doi.org/10.5056/jnm18068
  22. Irritable bowel syndrome in Asia: Pathogenesis, natural history, epidemiology, and management vol.33, pp.1, 2010, https://doi.org/10.1111/jgh.13987
  23. Current and future perspectives in the management of gastroesophageal reflux disease vol.1434, pp.1, 2010, https://doi.org/10.1111/nyas.13850